Independent Senior Adviser, Life Science Policy, HTA and Market Access
Carole is a respected leader in health technology assessment with considerable achievements in research, public and private sectors. She has unparalleled insight into the fast-evolving health technology innovation pipeline having pioneered NICE’s health technology evaluation programmes. Carole was an Executive Director at NICE from 2000-2018 and Chief Scientific Officer at the Association of the British Pharmaceutical Industry from 2018-2020. She was formerly President of Health Technology Assessment International and now has advisory roles including Life Science Advisor at NICE.
Carole is currently vice chair of the Medicines Discovery Catapult in the UK, was previously on Scientific Advisory Committee for Innovative Medicines Initiative (IMI) and holds non-Executive Director and advisory roles in scientific endeavours in the UK and abroad. Throughout her career, she has championed the public and private sector collaborating to ensure medical innovation benefits patients in a way that is sustainable for healthcare systems.
20 May 2021
BOOK YOUR PLACE NOW